India, May 10 -- Ovarian cancer is known for its subtle onset and non-specific symptoms that can mimic everyday digestive or hormonal issues. It is one of the most challenging gynaecological cancers to detect early. Ovarian cancer is usually hard to identify early, as it often does not cause noticeable symptoms in its initial stages. Symptoms may include persistent bloating, pelvic pain, early satiety, urinary urgency or frequency, and unexplained weight changes. These symptoms are often dismissed as harmless gastrointestinal or menstrual issues, which leads to delayed diagnosis. Approximately 1 in 70 women may develop ovarian cancer during their lifetime. The risk increases for women over 50, particularly those with a family history of ovarian, breast, or colorectal cancer. Treatment has evolved significantly with the introduction of precision medicine and less invasive surgical methods. Typically, the treatment plan involves a combination of surgery and chemotherapy, tailored to the individual's specific case, including the stage of cancer and their overall health. Cyto-reductive surgery (Debulking surgery) is a key treatment approach focused on removing as much of the tumour as possible. Nowadays, these procedures are performed with cutting-edge minimally invasive methods, allowing for quicker recoveries and a lower risk of complications. Systemic chemotherapy, with platinum-based agents, is often used after surgery to eliminate any remaining cancer cells. New targeted therapies, such as PARP inhibitors, have shown promising results, especially for patients with BRCA mutations or other genetic predispositions. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for patients with advanced abdominal cancers can improve survival rates and quality of life. Fertility Sparing Surgery (FSS) is performed in patients aiming to preserve a woman's fertility while treating the cancer. These therapies offer a more focused approach with fewer side effects compared to traditional treatment methods. Immunotherapy and intraperitoneal chemotherapy are currently being explored in clinical trials, providing new hope for patients with advanced or recurrent ovarian cancer. Although there is no sure-fire way to prevent ovarian cancer, several approaches can help reduce the risk. Genetic counselling and BRCA testing are important for individuals with a family history of the disease. In high-risk cases, preventive surgery, such as a salpingo-oophorectomy (removal of the ovaries and fallopian tubes), may be recommended. Using oral contraceptives, pregnancy, and breastfeeding have been linked to a reduced risk of ovarian cancer. Maintaining a healthy weight, avoiding tobacco, and undergoing regular pelvic exams are also key for early detection and prevention....